Stefano Milleri

1.8k total citations
37 papers, 747 citations indexed

About

Stefano Milleri is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Stefano Milleri has authored 37 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Physiology. Recurrent topics in Stefano Milleri's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Vitamin D Research Studies (3 papers) and Sexual function and dysfunction studies (3 papers). Stefano Milleri is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Vitamin D Research Studies (3 papers) and Sexual function and dysfunction studies (3 papers). Stefano Milleri collaborates with scholars based in Italy, United Kingdom and United States. Stefano Milleri's co-authors include Lisa Squassante, Luigi Ziviani, Alan Bye, Vincenzo Teneggi, Stephen T. Tiffany, Daniel S. Stein, Amy Peng, G P Ventresca, Laura Iavarone and Rachel Leeson and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Stefano Milleri

37 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefano Milleri Italy 17 218 188 111 96 73 37 747
Shaw-Ji Chen Taiwan 16 109 0.5× 197 1.0× 64 0.6× 43 0.4× 31 0.4× 43 816
Sankha Shubhra Chakrabarti India 16 139 0.6× 165 0.9× 95 0.9× 51 0.5× 47 0.6× 71 794
Bin Sun China 20 114 0.5× 328 1.7× 62 0.6× 56 0.6× 101 1.4× 55 1.1k
Yuping Wang China 17 327 1.5× 605 3.2× 42 0.4× 99 1.0× 51 0.7× 62 1.4k
Emma Lee United States 13 101 0.5× 139 0.7× 101 0.9× 74 0.8× 37 0.5× 37 979
Motohiro Matoba Japan 18 233 1.1× 126 0.7× 40 0.4× 66 0.7× 101 1.4× 57 782
Michela Bagnasco Italy 19 461 2.1× 103 0.5× 97 0.9× 43 0.4× 106 1.5× 27 1.2k
Aida Shirazi United States 7 175 0.8× 324 1.7× 168 1.5× 71 0.7× 27 0.4× 23 1.5k
R. A. A. Maes Netherlands 17 101 0.5× 177 0.9× 100 0.9× 46 0.5× 83 1.1× 32 788
Ágnes Fehér Hungary 16 182 0.8× 196 1.0× 67 0.6× 50 0.5× 50 0.7× 52 658

Countries citing papers authored by Stefano Milleri

Since Specialization
Citations

This map shows the geographic impact of Stefano Milleri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Milleri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Milleri more than expected).

Fields of papers citing papers by Stefano Milleri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Milleri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Milleri. The network helps show where Stefano Milleri may publish in the future.

Co-authorship network of co-authors of Stefano Milleri

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Milleri. A scholar is included among the top collaborators of Stefano Milleri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Milleri. Stefano Milleri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reni, Anna, Silvia Palmerio, Jessica Menis, et al.. (2024). Progresses and Pitfalls of Epigenetics in Solid Tumors Clinical Trials. International Journal of Molecular Sciences. 25(21). 11740–11740. 3 indexed citations
2.
Zecchetto, Camilla, Valeria Merz, Silvia Pietrobono, et al.. (2023). Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab. Journal of Personalized Medicine. 13(3). 508–508. 1 indexed citations
3.
Peyruchaud, Olivier, Pritom Shah, Anne Cheasty, et al.. (2023). Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors. Immuno-Oncology Technology. 18. 100384–100384. 16 indexed citations
4.
Agrati, Chiara, Stefania Capone, Concetta Castilletti, et al.. (2021). Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19. npj Vaccines. 6(1). 131–131. 7 indexed citations
5.
Milleri, Stefano, Marion M. Deken, Alan Carruthers, et al.. (2021). 131P Translating a novel autotaxin inhibitor from preclinical proof of concept in pancreatic cancer to a biomarker response in human subjects. Annals of Oncology. 32. S1434–S1434. 1 indexed citations
6.
Navarra, Pierluigi, et al.. (2021). Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies. European Journal of Drug Metabolism and Pharmacokinetics. 46(3). 375–384. 3 indexed citations
7.
Fassio, Angelo, Giovanni Adami, Maurizio Rossini, et al.. (2020). Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study. Nutrients. 12(6). 1553–1553. 40 indexed citations
10.
Castellazzi, Anna Maria, Sara Carlotta Tagliacarne, Sara Soldi, et al.. (2018). Stress and Immune Function. Journal of Clinical Gastroenterology. 52(Supplement 1). S66–S67. 7 indexed citations
11.
Brambilla, Frăncesca, Giulia Perini, Mariangela Serra, et al.. (2013). Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals. Psychoneuroendocrinology. 38(10). 2234–2242. 7 indexed citations
13.
Teneggi, Vincenzo, Stephen T. Tiffany, Lisa Squassante, et al.. (2005). Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. Psychopharmacology. 183(1). 1–12. 35 indexed citations
14.
Squassante, Lisa, et al.. (2003). Dose Linearity of Lacidipine Pharmacokinetics After Single and Repeated Oral Doses in Healthy Volunteers. Clinical Pharmacokinetics. 42(1). 99–106. 13 indexed citations
15.
Teneggi, Vincenzo, Lisa Squassante, Laura Iavarone, et al.. (2002). Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal‐induced craving. British Journal of Clinical Pharmacology. 54(4). 407–414. 33 indexed citations
16.
Ziviani, Luigi, et al.. (2001). The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects. British Journal of Clinical Pharmacology. 51(2). 147–152. 20 indexed citations
17.
Kirby, Suyong Yun, Christine Falcoz, Matthieu Daniel, et al.. (2001). Salmeterol and fluticasone propionate given as a combination. European Journal of Clinical Pharmacology. 56(11). 781–791. 40 indexed citations
18.
Ziviani, Luigi, et al.. (2001). The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects. British Journal of Clinical Pharmacology. 51(2). 147–152. 3 indexed citations
19.
Peng, Amy, Stefano Milleri, & Daniel S. Stein. (2000). Direct Measurement of the Anti-Influenza Agent Zanamivir in the Respiratory Tract following Inhalation. Antimicrobial Agents and Chemotherapy. 44(7). 1974–1976. 51 indexed citations
20.
Peroni, M., et al.. (2000). Evaluation of the readability of information sheets for healthy volunteers in phase-I trials. European Journal of Clinical Pharmacology. 56(5). 371–374. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026